Nano-Derived Therapeutic Formulations with Curcumin in Inflammation-Related Diseases
Due to its vast therapeutic potential, the plant-derived polyphenol curcumin is utilized in an ever-growing number of health-related applications. Here, we report the extraction methodologies, therapeutic properties, advantages and disadvantages linked to curcumin employment, and the new strategies...
Gespeichert in:
Veröffentlicht in: | Oxidative medicine and cellular longevity 2021, Vol.2021 (1), p.3149223 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 1 |
container_start_page | 3149223 |
container_title | Oxidative medicine and cellular longevity |
container_volume | 2021 |
creator | Quispe, Cristina Cruz-Martins, Natália Manca, Maria Letizia Manconi, Maria Sytar, Oksana Hudz, Nataliia Shanaida, Mariia Kumar, Manoj Taheri, Yasaman Martorell, Miquel Sharifi-Rad, Javad Pintus, Gianfranco Cho, William C. |
description | Due to its vast therapeutic potential, the plant-derived polyphenol curcumin is utilized in an ever-growing number of health-related applications. Here, we report the extraction methodologies, therapeutic properties, advantages and disadvantages linked to curcumin employment, and the new strategies addressed to improve its effectiveness by employing advanced nanocarriers. The emerging nanotechnology applications used to enhance CUR bioavailability and its targeted delivery in specific pathological conditions are collected and discussed. In particular, new aspects concerning the main strategic nanocarriers employed for treating inflammation and oxidative stress-related diseases are reported and discussed, with specific emphasis on those topically employed in conditions such as wounds, arthritis, or psoriasis and others used in pathologies such as bowel (colitis), neurodegenerative (Alzheimer’s or dementia), cardiovascular (atherosclerosis), and lung (asthma and chronic obstructive pulmonary disease) diseases. A brief overview of the relevant clinical trials is also included. We believe the review can provide the readers with an overview of the nanostrategies currently employed to improve CUR therapeutic applications in the highlighted pathological conditions. |
doi_str_mv | 10.1155/2021/3149223 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8470924</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2576544747</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-2053757906eabf6d590bb297953eae7cd5067f3b907001d52eed769cd0e3a4f3</originalsourceid><addsrcrecordid>eNp9kU1Lw0AQhhdR_L55loBHjZ39yroXQapVoShI7ssmmZiVJqm7ScV_b2pr0YswMAPzzDvDvIScULikVMoRA0ZHnArNGN8i-1QLFoPWYntTA-yRgxDeABLOBN0le1zIK5HQZJ-kT7Zp41v0boFFlFbo7Rz7zuXRpPV1P7Oda5sQfbiuisa9z_vaNdEQj005s3X93Y5fcOCG8VsX0AYMR2SntLOAx-t8SNLJXTp-iKfP94_jm2mcCyW7mIHkSioNCdqsTAqpIcuYVlpytKjyQkKiSp5pUAC0kAyxUInOC0BuRckPyfVKdt5nNRY5Np23MzP3rrb-07TWmb-dxlXmtV2YK6FAMzEInK0FfPveY-jMW9v7ZjjZMKkSKYQSaqAuVlTu2xA8lpsNFMzSArO0wKwtGPDT31dt4J-fD8D5CqhcU9gP97_cFyY9jyw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2576544747</pqid></control><display><type>article</type><title>Nano-Derived Therapeutic Formulations with Curcumin in Inflammation-Related Diseases</title><source>MEDLINE</source><source>Wiley Online Library Open Access</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>PubMed Central Open Access</source><creator>Quispe, Cristina ; Cruz-Martins, Natália ; Manca, Maria Letizia ; Manconi, Maria ; Sytar, Oksana ; Hudz, Nataliia ; Shanaida, Mariia ; Kumar, Manoj ; Taheri, Yasaman ; Martorell, Miquel ; Sharifi-Rad, Javad ; Pintus, Gianfranco ; Cho, William C.</creator><contributor>de Oliveira, Felipe L. ; Felipe L de Oliveira</contributor><creatorcontrib>Quispe, Cristina ; Cruz-Martins, Natália ; Manca, Maria Letizia ; Manconi, Maria ; Sytar, Oksana ; Hudz, Nataliia ; Shanaida, Mariia ; Kumar, Manoj ; Taheri, Yasaman ; Martorell, Miquel ; Sharifi-Rad, Javad ; Pintus, Gianfranco ; Cho, William C. ; de Oliveira, Felipe L. ; Felipe L de Oliveira</creatorcontrib><description>Due to its vast therapeutic potential, the plant-derived polyphenol curcumin is utilized in an ever-growing number of health-related applications. Here, we report the extraction methodologies, therapeutic properties, advantages and disadvantages linked to curcumin employment, and the new strategies addressed to improve its effectiveness by employing advanced nanocarriers. The emerging nanotechnology applications used to enhance CUR bioavailability and its targeted delivery in specific pathological conditions are collected and discussed. In particular, new aspects concerning the main strategic nanocarriers employed for treating inflammation and oxidative stress-related diseases are reported and discussed, with specific emphasis on those topically employed in conditions such as wounds, arthritis, or psoriasis and others used in pathologies such as bowel (colitis), neurodegenerative (Alzheimer’s or dementia), cardiovascular (atherosclerosis), and lung (asthma and chronic obstructive pulmonary disease) diseases. A brief overview of the relevant clinical trials is also included. We believe the review can provide the readers with an overview of the nanostrategies currently employed to improve CUR therapeutic applications in the highlighted pathological conditions.</description><identifier>ISSN: 1942-0900</identifier><identifier>EISSN: 1942-0994</identifier><identifier>DOI: 10.1155/2021/3149223</identifier><identifier>PMID: 34584616</identifier><language>eng</language><publisher>United States: Hindawi</publisher><subject>Antioxidants ; Arthritis - drug therapy ; Arthritis - pathology ; Bioavailability ; Biological Availability ; Chronic illnesses ; Curcumin - chemistry ; Curcumin - therapeutic use ; Dietary supplements ; Disease ; Drug Carriers - chemistry ; Drug Stability ; Gene expression ; Humans ; Inflammation ; Kinases ; Metabolism ; Metabolites ; Nanoparticles ; Nanotechnology ; Neurodegenerative Diseases - drug therapy ; Neurodegenerative Diseases - pathology ; Oils & fats ; Oxidative stress ; Plants, Medicinal - chemistry ; Plants, Medicinal - metabolism ; Review</subject><ispartof>Oxidative medicine and cellular longevity, 2021, Vol.2021 (1), p.3149223</ispartof><rights>Copyright © 2021 Cristina Quispe et al.</rights><rights>Copyright © 2021 Cristina Quispe et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2021 Cristina Quispe et al. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-2053757906eabf6d590bb297953eae7cd5067f3b907001d52eed769cd0e3a4f3</citedby><cites>FETCH-LOGICAL-c475t-2053757906eabf6d590bb297953eae7cd5067f3b907001d52eed769cd0e3a4f3</cites><orcidid>0000-0002-3031-7733 ; 0000-0003-3183-7623 ; 0000-0002-4192-6497 ; 0000-0002-0836-236X ; 0000-0002-7301-8151 ; 0000-0003-4174-4586 ; 0000-0002-5934-5201 ; 0000-0002-2240-0852</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470924/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470924/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,4010,27900,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34584616$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>de Oliveira, Felipe L.</contributor><contributor>Felipe L de Oliveira</contributor><creatorcontrib>Quispe, Cristina</creatorcontrib><creatorcontrib>Cruz-Martins, Natália</creatorcontrib><creatorcontrib>Manca, Maria Letizia</creatorcontrib><creatorcontrib>Manconi, Maria</creatorcontrib><creatorcontrib>Sytar, Oksana</creatorcontrib><creatorcontrib>Hudz, Nataliia</creatorcontrib><creatorcontrib>Shanaida, Mariia</creatorcontrib><creatorcontrib>Kumar, Manoj</creatorcontrib><creatorcontrib>Taheri, Yasaman</creatorcontrib><creatorcontrib>Martorell, Miquel</creatorcontrib><creatorcontrib>Sharifi-Rad, Javad</creatorcontrib><creatorcontrib>Pintus, Gianfranco</creatorcontrib><creatorcontrib>Cho, William C.</creatorcontrib><title>Nano-Derived Therapeutic Formulations with Curcumin in Inflammation-Related Diseases</title><title>Oxidative medicine and cellular longevity</title><addtitle>Oxid Med Cell Longev</addtitle><description>Due to its vast therapeutic potential, the plant-derived polyphenol curcumin is utilized in an ever-growing number of health-related applications. Here, we report the extraction methodologies, therapeutic properties, advantages and disadvantages linked to curcumin employment, and the new strategies addressed to improve its effectiveness by employing advanced nanocarriers. The emerging nanotechnology applications used to enhance CUR bioavailability and its targeted delivery in specific pathological conditions are collected and discussed. In particular, new aspects concerning the main strategic nanocarriers employed for treating inflammation and oxidative stress-related diseases are reported and discussed, with specific emphasis on those topically employed in conditions such as wounds, arthritis, or psoriasis and others used in pathologies such as bowel (colitis), neurodegenerative (Alzheimer’s or dementia), cardiovascular (atherosclerosis), and lung (asthma and chronic obstructive pulmonary disease) diseases. A brief overview of the relevant clinical trials is also included. We believe the review can provide the readers with an overview of the nanostrategies currently employed to improve CUR therapeutic applications in the highlighted pathological conditions.</description><subject>Antioxidants</subject><subject>Arthritis - drug therapy</subject><subject>Arthritis - pathology</subject><subject>Bioavailability</subject><subject>Biological Availability</subject><subject>Chronic illnesses</subject><subject>Curcumin - chemistry</subject><subject>Curcumin - therapeutic use</subject><subject>Dietary supplements</subject><subject>Disease</subject><subject>Drug Carriers - chemistry</subject><subject>Drug Stability</subject><subject>Gene expression</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Kinases</subject><subject>Metabolism</subject><subject>Metabolites</subject><subject>Nanoparticles</subject><subject>Nanotechnology</subject><subject>Neurodegenerative Diseases - drug therapy</subject><subject>Neurodegenerative Diseases - pathology</subject><subject>Oils & fats</subject><subject>Oxidative stress</subject><subject>Plants, Medicinal - chemistry</subject><subject>Plants, Medicinal - metabolism</subject><subject>Review</subject><issn>1942-0900</issn><issn>1942-0994</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kU1Lw0AQhhdR_L55loBHjZ39yroXQapVoShI7ssmmZiVJqm7ScV_b2pr0YswMAPzzDvDvIScULikVMoRA0ZHnArNGN8i-1QLFoPWYntTA-yRgxDeABLOBN0le1zIK5HQZJ-kT7Zp41v0boFFlFbo7Rz7zuXRpPV1P7Oda5sQfbiuisa9z_vaNdEQj005s3X93Y5fcOCG8VsX0AYMR2SntLOAx-t8SNLJXTp-iKfP94_jm2mcCyW7mIHkSioNCdqsTAqpIcuYVlpytKjyQkKiSp5pUAC0kAyxUInOC0BuRckPyfVKdt5nNRY5Np23MzP3rrb-07TWmb-dxlXmtV2YK6FAMzEInK0FfPveY-jMW9v7ZjjZMKkSKYQSaqAuVlTu2xA8lpsNFMzSArO0wKwtGPDT31dt4J-fD8D5CqhcU9gP97_cFyY9jyw</recordid><startdate>2021</startdate><enddate>2021</enddate><creator>Quispe, Cristina</creator><creator>Cruz-Martins, Natália</creator><creator>Manca, Maria Letizia</creator><creator>Manconi, Maria</creator><creator>Sytar, Oksana</creator><creator>Hudz, Nataliia</creator><creator>Shanaida, Mariia</creator><creator>Kumar, Manoj</creator><creator>Taheri, Yasaman</creator><creator>Martorell, Miquel</creator><creator>Sharifi-Rad, Javad</creator><creator>Pintus, Gianfranco</creator><creator>Cho, William C.</creator><general>Hindawi</general><general>Hindawi Limited</general><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3031-7733</orcidid><orcidid>https://orcid.org/0000-0003-3183-7623</orcidid><orcidid>https://orcid.org/0000-0002-4192-6497</orcidid><orcidid>https://orcid.org/0000-0002-0836-236X</orcidid><orcidid>https://orcid.org/0000-0002-7301-8151</orcidid><orcidid>https://orcid.org/0000-0003-4174-4586</orcidid><orcidid>https://orcid.org/0000-0002-5934-5201</orcidid><orcidid>https://orcid.org/0000-0002-2240-0852</orcidid></search><sort><creationdate>2021</creationdate><title>Nano-Derived Therapeutic Formulations with Curcumin in Inflammation-Related Diseases</title><author>Quispe, Cristina ; Cruz-Martins, Natália ; Manca, Maria Letizia ; Manconi, Maria ; Sytar, Oksana ; Hudz, Nataliia ; Shanaida, Mariia ; Kumar, Manoj ; Taheri, Yasaman ; Martorell, Miquel ; Sharifi-Rad, Javad ; Pintus, Gianfranco ; Cho, William C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-2053757906eabf6d590bb297953eae7cd5067f3b907001d52eed769cd0e3a4f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antioxidants</topic><topic>Arthritis - drug therapy</topic><topic>Arthritis - pathology</topic><topic>Bioavailability</topic><topic>Biological Availability</topic><topic>Chronic illnesses</topic><topic>Curcumin - chemistry</topic><topic>Curcumin - therapeutic use</topic><topic>Dietary supplements</topic><topic>Disease</topic><topic>Drug Carriers - chemistry</topic><topic>Drug Stability</topic><topic>Gene expression</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Kinases</topic><topic>Metabolism</topic><topic>Metabolites</topic><topic>Nanoparticles</topic><topic>Nanotechnology</topic><topic>Neurodegenerative Diseases - drug therapy</topic><topic>Neurodegenerative Diseases - pathology</topic><topic>Oils & fats</topic><topic>Oxidative stress</topic><topic>Plants, Medicinal - chemistry</topic><topic>Plants, Medicinal - metabolism</topic><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Quispe, Cristina</creatorcontrib><creatorcontrib>Cruz-Martins, Natália</creatorcontrib><creatorcontrib>Manca, Maria Letizia</creatorcontrib><creatorcontrib>Manconi, Maria</creatorcontrib><creatorcontrib>Sytar, Oksana</creatorcontrib><creatorcontrib>Hudz, Nataliia</creatorcontrib><creatorcontrib>Shanaida, Mariia</creatorcontrib><creatorcontrib>Kumar, Manoj</creatorcontrib><creatorcontrib>Taheri, Yasaman</creatorcontrib><creatorcontrib>Martorell, Miquel</creatorcontrib><creatorcontrib>Sharifi-Rad, Javad</creatorcontrib><creatorcontrib>Pintus, Gianfranco</creatorcontrib><creatorcontrib>Cho, William C.</creatorcontrib><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oxidative medicine and cellular longevity</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Quispe, Cristina</au><au>Cruz-Martins, Natália</au><au>Manca, Maria Letizia</au><au>Manconi, Maria</au><au>Sytar, Oksana</au><au>Hudz, Nataliia</au><au>Shanaida, Mariia</au><au>Kumar, Manoj</au><au>Taheri, Yasaman</au><au>Martorell, Miquel</au><au>Sharifi-Rad, Javad</au><au>Pintus, Gianfranco</au><au>Cho, William C.</au><au>de Oliveira, Felipe L.</au><au>Felipe L de Oliveira</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nano-Derived Therapeutic Formulations with Curcumin in Inflammation-Related Diseases</atitle><jtitle>Oxidative medicine and cellular longevity</jtitle><addtitle>Oxid Med Cell Longev</addtitle><date>2021</date><risdate>2021</risdate><volume>2021</volume><issue>1</issue><spage>3149223</spage><pages>3149223-</pages><issn>1942-0900</issn><eissn>1942-0994</eissn><abstract>Due to its vast therapeutic potential, the plant-derived polyphenol curcumin is utilized in an ever-growing number of health-related applications. Here, we report the extraction methodologies, therapeutic properties, advantages and disadvantages linked to curcumin employment, and the new strategies addressed to improve its effectiveness by employing advanced nanocarriers. The emerging nanotechnology applications used to enhance CUR bioavailability and its targeted delivery in specific pathological conditions are collected and discussed. In particular, new aspects concerning the main strategic nanocarriers employed for treating inflammation and oxidative stress-related diseases are reported and discussed, with specific emphasis on those topically employed in conditions such as wounds, arthritis, or psoriasis and others used in pathologies such as bowel (colitis), neurodegenerative (Alzheimer’s or dementia), cardiovascular (atherosclerosis), and lung (asthma and chronic obstructive pulmonary disease) diseases. A brief overview of the relevant clinical trials is also included. We believe the review can provide the readers with an overview of the nanostrategies currently employed to improve CUR therapeutic applications in the highlighted pathological conditions.</abstract><cop>United States</cop><pub>Hindawi</pub><pmid>34584616</pmid><doi>10.1155/2021/3149223</doi><orcidid>https://orcid.org/0000-0002-3031-7733</orcidid><orcidid>https://orcid.org/0000-0003-3183-7623</orcidid><orcidid>https://orcid.org/0000-0002-4192-6497</orcidid><orcidid>https://orcid.org/0000-0002-0836-236X</orcidid><orcidid>https://orcid.org/0000-0002-7301-8151</orcidid><orcidid>https://orcid.org/0000-0003-4174-4586</orcidid><orcidid>https://orcid.org/0000-0002-5934-5201</orcidid><orcidid>https://orcid.org/0000-0002-2240-0852</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1942-0900 |
ispartof | Oxidative medicine and cellular longevity, 2021, Vol.2021 (1), p.3149223 |
issn | 1942-0900 1942-0994 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8470924 |
source | MEDLINE; Wiley Online Library Open Access; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection; PubMed Central Open Access |
subjects | Antioxidants Arthritis - drug therapy Arthritis - pathology Bioavailability Biological Availability Chronic illnesses Curcumin - chemistry Curcumin - therapeutic use Dietary supplements Disease Drug Carriers - chemistry Drug Stability Gene expression Humans Inflammation Kinases Metabolism Metabolites Nanoparticles Nanotechnology Neurodegenerative Diseases - drug therapy Neurodegenerative Diseases - pathology Oils & fats Oxidative stress Plants, Medicinal - chemistry Plants, Medicinal - metabolism Review |
title | Nano-Derived Therapeutic Formulations with Curcumin in Inflammation-Related Diseases |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T08%3A53%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nano-Derived%20Therapeutic%20Formulations%20with%20Curcumin%20in%20Inflammation-Related%20Diseases&rft.jtitle=Oxidative%20medicine%20and%20cellular%20longevity&rft.au=Quispe,%20Cristina&rft.date=2021&rft.volume=2021&rft.issue=1&rft.spage=3149223&rft.pages=3149223-&rft.issn=1942-0900&rft.eissn=1942-0994&rft_id=info:doi/10.1155/2021/3149223&rft_dat=%3Cproquest_pubme%3E2576544747%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2576544747&rft_id=info:pmid/34584616&rfr_iscdi=true |